This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
LGI Homes (LGIH) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LGI Homes (LGIH) delivered earnings and revenue surprises of +12.40% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LGIHPositive Net Change HHHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Camtek (CAMT) Q2 Earnings Meet Estimates
by Zacks Equity Research
Camtek (CAMT) delivered earnings and revenue surprises of 0.00% and +1.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CAMTPositive Net Change KEYSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 0.00% and -48.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TNGXNegative Net Change ARCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UL Solutions Inc. (ULS) delivered earnings and revenue surprises of +10.64% and +0.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ULSPositive Net Change BWMNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Knife River (KNF) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Knife River (KNF) delivered earnings and revenue surprises of -29.92% and -3.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KNFPositive Net Change JBIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LCI (LCII) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
LCI (LCII) delivered earnings and revenue surprises of +7.66% and +2.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LCIIPositive Net Change WKHSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Madrigal (MDGL) delivered earnings and revenue surprises of +45.40% and +32.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MDGLPositive Net Change PROFPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sealed Air (SEE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Sealed Air (SEE) delivered earnings and revenue surprises of +23.61% and +1.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SEEPositive Net Change KRTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AdaptHealth (AHCO) delivered earnings and revenue surprises of -93.33% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AHCOPositive Net Change PBHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AXGNPositive Net Change PRCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beam Therapeutics (BEAM) delivered earnings and revenue surprises of +3.85% and -38.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BEAMPositive Net Change CVACPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of +36.36% and +4.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CWKPositive Net Change LEGHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fidelity National Information Services (FIS) Matches Q2 Earnings Estimates
by Zacks Equity Research
Fidelity National (FIS) delivered earnings and revenue surprises of 0.00% and +1.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FISPositive Net Change DLOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
J&J Snack Foods (JJSF) delivered earnings and revenue surprises of +14.94% and +1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JJSFPositive Net Change HAINPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
AC Immune (ACIU) delivered earnings and revenue surprises of -25.00% and -57.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACIUPositive Net Change FTREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Axcelis Technologies (ACLS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Axcelis (ACLS) delivered earnings and revenue surprises of +54.79% and +5.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACLSPositive Net Change VECOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ZTSPositive Net Change PRPHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of -13.64% and +11.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RYTMPositive Net Change ROIVPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Spire (SR) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Spire (SR) delivered earnings and revenue surprises of +111.11% and +2.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SRPositive Net Change SREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Yum Brands (YUM) Misses Q2 Earnings Estimates
by Zacks Equity Research
Yum (YUM) delivered earnings and revenue surprises of -0.69% and +0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
YUMNegative Net Change PZZAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Archer Daniels Midland (ADM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
ADM (ADM) delivered earnings and revenue surprises of +5.68% and +0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ADMPositive Net Change DOLEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Broadridge Financial Solutions (BR) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Broadridge Financial (BR) delivered earnings and revenue surprises of +1.14% and +0.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BRPositive Net Change BMBLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +9.68% and -0.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FHTXPositive Net Change EXASPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Marriott International (MAR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Marriott (MAR) delivered earnings and revenue surprises of +0.38% and +1.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MARPositive Net Change SHCONo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Novanta (NOVT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Novanta (NOVT) delivered earnings and revenue surprises of +2.70% and +1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NOVTPositive Net Change ALNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank